SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis

Mahesh M. Umapathysivam, Bethany Morgan, Joshua M. Inglis, Emily Meyer, Danny Liew, Venkatesan Thiruvenkatarajan, David Jesudason

JAMA network open（2024）

引用 0|浏览14

暂无评分

摘要

This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor-associated ketoacidosis compared with that of type 1 diabetes-associated ketoacidosis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要